Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Thermo Fisher Scientific (NY: TMO )

556.99 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Jan 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2
...
16 17 18 19 20 21 22 23 Next >
10 Biggest Price Target Changes For Thursday
Oppenheimer lowered Teladoc Health, Inc. (NYSE:TDOC 
Via Benzinga
Thermo Fisher Stock Strength Rating Climbs To 81; Medical Devices Maker Shows Market Leadership
Thermo Fisher Scientific shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 81. 
Via Investor's Business Daily
Thermo Fisher's COVID-19 Response Revenue Accounts For 22% In Q3 Sales, Boosts FY21 Outlook
Thermo Fisher Scientific Inc (NYSE: TMO) has posted Q3 revenues of $9.33 billion, up 9% Y/Y, beating the consensus of $8.39 billion. Organic revenue growth from... 
Via Benzinga
Exposures COVID-19
Thermo Fisher Scientific: Q3 Earnings Insights
Thermo Fisher Scientific (NYSE:TMO) reported its Q3 earnings results on Wednesday, October 27, 2021 at 06:00 AM. Here's what investors need to know about the... 
Via Benzinga
Earnings Scheduled For October 27, 2021
Companies Reporting Before The Bell • McDonald's (NYSE:MCD) is expected to report quarterly earnings at $2.46 per share on revenue of $6.03 billion. • General... 
Via Benzinga
TMO Stock Forecast: The World Leader In Serving Science
TMO is a strong buy stock, it is a stable and powerful technology stock with good management and a strong financial position, which is reasonable for long-term holding. 
Via Talk Markets
Tuesday Market Coverage
Thermo Electron fell on the publication of its social responsibility report today. 
Via Talk Markets
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength... 
Via Benzinga
Exposures Product Safety
Wednesday Market Coverage
Today gold rose again despite the active market for bitcoin and the lower Chinese demand for mine products like iron and coal. 
Via Talk Markets
Where Thermo Fisher Scientific Stands With Analysts
Thermo Fisher Scientific (NYSE:TMO) has observed the following analyst rating... 
Via Benzinga
Chinese Growth Level
The hot news today was a much weaker Chinese growth level this year, of 4.9% because of supply chain issues. 
Via Talk Markets
3 Dividend Stocks That Hiked Their Payouts by More Than 10% This Year
And more rate hikes are likely in their future. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2021
Upgrades For Iridium Communications Inc (NASDAQ:IRD... 
Via Benzinga
Friday Market Coverage
New hiring again failed to rise in Sept., the 2nd month in a row which may be good news because it could delay the Fed tapering. 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Semiconductor Shortage Hits Supply Chain For MedTech Industry
According to a study commissioned by AdvaMed, the global semiconductor chip shortage is causing delays, order cancellations, and other supply disruptions at MedTech companies.... 
Via Benzinga
FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations
The FDA has issued a letter to establish additional conditions of Emergency Use Authorizations (EUAs) manufacturers of COVID-19 tests. The agency has asked COVID-19... 
Via Benzinga
Exposures COVID-19 Product Safety
'Fast Money Halftime Report' Picks For September 23
On CNBC's "Fast Money Halftime Report," Karen Firestone said Thermo Fisher Scientific Inc. (NYSE: TMO) had a great analyst day. It raised guidance for 2022 and the... 
Via Benzinga
Expert Ratings For Thermo Fisher Scientific
Thermo Fisher Scientific (NYSE:TMO) has observed the following analyst rating... 
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Piper Sandler boosted the price target for Adobe Inc. (NASDAQ: ADBE) from $600 to $670. Adobe shares fell 3.5% to $623.50 in pre-market trading. Keybanc reduced the price target... 
Via Benzinga
A Day Of Huge Market Moves
It was a day of huge market moves and several reporting companies. Trudeau won but did not get a parliamentary majority. 
Via Talk Markets
Pharma, Tech and Finance
Good news on some drugs was not enough to boost stock markets. 
Via Talk Markets
Analyst Ratings For Thermo Fisher Scientific
Within the last quarter, Thermo Fisher Scientific (NYSE:TMO) has observed the... 
Via Benzinga
10 Biggest Price Target Changes For Monday
Barclays boosted Upstart Holdings, Inc. (NASDAQ:UPST 
Via Benzinga
48 Biggest Movers From Friday
Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by... 
Via Benzinga
Why Thermo Fisher Shares Are Trading Higher Today
Thermo Fisher Scientific Inc (NYSE: TMO) is trading higher Friday after the company issued full-year 2022 financial guidance above analyst estimates. Thermo Fisher... 
Via Benzinga
Thermo Fisher Called For A Covid Testing Dive, And Soared — Here's Why
Thermo Fisher Scientific crushed guidance expectations for 2022 and beyond on Friday, and TMO stock surged to a fresh high. 
Via Investor's Business Daily
Investor React Positively To Thermo Fisher's Annual Guidance
Thermo Fisher Scientific Inc (NYSE: TMO) provided initial revenue and earnings guidance for 2022 while reiterating previously disclosed financial guidance for full... 
Via Benzinga
Takeda's Exkivity Scores FDA Nod As First Oral Therapy For Lung Cancer With EGFR Exon20 Insertion
The FDA has approved Takeda Pharmaceutical Co Ltd's (NYSE: TAK) Exkivity (mobocertinib) for non-small cell lung cancer (NSCLC) settings. The approval comes for... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)... 
Via Benzinga
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (... 
Via Benzinga
< Previous 1 2
...
16 17 18 19 20 21 22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.